![Current Oncology | Free Full-Text | Evaluation of Surgical Approaches and Use of Adjuvant Radiotherapy with Respect to Oncologic Outcomes in the Management of Clinically Early-Stage Cervical Carcinoma Current Oncology | Free Full-Text | Evaluation of Surgical Approaches and Use of Adjuvant Radiotherapy with Respect to Oncologic Outcomes in the Management of Clinically Early-Stage Cervical Carcinoma](https://www.mdpi.com/curroncol/curroncol-29-00748/article_deploy/html/images/curroncol-29-00748-g003-550.jpg)
Current Oncology | Free Full-Text | Evaluation of Surgical Approaches and Use of Adjuvant Radiotherapy with Respect to Oncologic Outcomes in the Management of Clinically Early-Stage Cervical Carcinoma
Cervical cancer treated with reduced-volume intensity-modulated radiation therapy base on Sedlis criteria (NCCN VS RTOG)
![PDF) Promising treatment results of adjuvant chemotherapy following radical hysterectomy for intermediate risk stage 1B cervical cancer PDF) Promising treatment results of adjuvant chemotherapy following radical hysterectomy for intermediate risk stage 1B cervical cancer](https://www.researchgate.net/profile/Heung-Kim/publication/259272105/figure/tbl2/AS:203040591224847@1425420057580/Criterias-of-intermediate-risk-tumors-Classic-vs-GOG-criteria_Q320.jpg)
PDF) Promising treatment results of adjuvant chemotherapy following radical hysterectomy for intermediate risk stage 1B cervical cancer
![Table 2 from Promising treatment results of adjuvant chemotherapy following radical hysterectomy for intermediate risk stage 1B cervical cancer | Semantic Scholar Table 2 from Promising treatment results of adjuvant chemotherapy following radical hysterectomy for intermediate risk stage 1B cervical cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/eb57ca3e914189d8efe867b5730c82d6bd3fbce6/3-Table2-1.png)
Table 2 from Promising treatment results of adjuvant chemotherapy following radical hysterectomy for intermediate risk stage 1B cervical cancer | Semantic Scholar
![Frontiers | Prognostic Assessment of Cervical Cancer Patients by Clinical Staging and Surgical-Pathological Factor: A Support Vector Machine-Based Approach Frontiers | Prognostic Assessment of Cervical Cancer Patients by Clinical Staging and Surgical-Pathological Factor: A Support Vector Machine-Based Approach](https://www.frontiersin.org/files/Articles/554572/fonc-10-01353-HTML/image_m/fonc-10-01353-g003.jpg)
Frontiers | Prognostic Assessment of Cervical Cancer Patients by Clinical Staging and Surgical-Pathological Factor: A Support Vector Machine-Based Approach
![ESGO 2022: Sentinel node biopsy diminishes de use of adjuvant therapy in women with early cervical cancer in the SUCCOR cohort ESGO 2022: Sentinel node biopsy diminishes de use of adjuvant therapy in women with early cervical cancer in the SUCCOR cohort](https://larvolclin.s3.us-west-2.amazonaws.com/resize_1667212745278426095635fa5c9ed981.jpg)
ESGO 2022: Sentinel node biopsy diminishes de use of adjuvant therapy in women with early cervical cancer in the SUCCOR cohort
![Table 1 from Cervical cancer treated with reduced-volume intensity-modulated radiation therapy base on Sedlis criteria (NCCN VS RTOG). | Semantic Scholar Table 1 from Cervical cancer treated with reduced-volume intensity-modulated radiation therapy base on Sedlis criteria (NCCN VS RTOG). | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6ddc3cac14dade2a979d9f70b660e32f3ee79e66/11-Table1-1.png)
Table 1 from Cervical cancer treated with reduced-volume intensity-modulated radiation therapy base on Sedlis criteria (NCCN VS RTOG). | Semantic Scholar
![Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology in: Journal of the National Comprehensive Cancer Network Volume 17 Issue 1 (2019) Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology in: Journal of the National Comprehensive Cancer Network Volume 17 Issue 1 (2019)](https://jnccn.org/view/journals/jnccn/17/1/full-0064fig11.jpg)
Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology in: Journal of the National Comprehensive Cancer Network Volume 17 Issue 1 (2019)
![RadOnc Tables on Twitter: "New nomograms to replace Sedlis criteria 🚀 A better way to determine risk for post-op cervix ✨Nomograms for both SCC & ACC ✨Sedlis criteria is for 30% chance RadOnc Tables on Twitter: "New nomograms to replace Sedlis criteria 🚀 A better way to determine risk for post-op cervix ✨Nomograms for both SCC & ACC ✨Sedlis criteria is for 30% chance](https://pbs.twimg.com/media/E8DSeO6XEAIKQx1.png)
RadOnc Tables on Twitter: "New nomograms to replace Sedlis criteria 🚀 A better way to determine risk for post-op cervix ✨Nomograms for both SCC & ACC ✨Sedlis criteria is for 30% chance
![Carcinoma of the Cervix. Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology - PDF Free Download Carcinoma of the Cervix. Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology - PDF Free Download](https://docplayer.net/docs-images/46/21322886/images/page_11.jpg)
Carcinoma of the Cervix. Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology - PDF Free Download
![From FIGO-2009 to FIGO-2018 in women with early-stage cervical cancer; Does the revised staging reflect risk groups? - ScienceDirect From FIGO-2009 to FIGO-2018 in women with early-stage cervical cancer; Does the revised staging reflect risk groups? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S009082582101324X-ga1.jpg)
From FIGO-2009 to FIGO-2018 in women with early-stage cervical cancer; Does the revised staging reflect risk groups? - ScienceDirect
![Validation of tumour-free distance as novel prognostic marker in early-stage cervical cancer: a retrospective, single-centre, cohort study | British Journal of Cancer Validation of tumour-free distance as novel prognostic marker in early-stage cervical cancer: a retrospective, single-centre, cohort study | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-021-01384-z/MediaObjects/41416_2021_1384_Fig1_HTML.png)
Validation of tumour-free distance as novel prognostic marker in early-stage cervical cancer: a retrospective, single-centre, cohort study | British Journal of Cancer
![Long-term treatment outcomes/toxicities of definite chemoradiotherapy (intensity-modulated radiation therapy) for early-stage “bulky” cervical cancer and survival impact of histological subtype - ScienceDirect Long-term treatment outcomes/toxicities of definite chemoradiotherapy (intensity-modulated radiation therapy) for early-stage “bulky” cervical cancer and survival impact of histological subtype - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0929664622003965-figs1.jpg)